Author/Authors :
Moghimipour, Eskandar Department of Pharmaceutics, School of Pharmacy, Jondishapour University of Medical Sciences, Ahwaz , Jalali, Amir Department of Pharmacologys, School of Pharmacy,Shaheed Beheshti University of Medical Sciences, Tehran , Sajjadi Tabassi, Abolghassem Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad , Löbenberg, Raimar Faculty of Pharmacy and Pharmaceutical Science, Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta, Canada
Abstract :
There have been numerous efforts to formulate insulin into an oral dosage form. The major
problems involved with the oral administration of insulin are acidic and enzymatic
decomposition by the gastric medium, and poor absorption in the small intestine due to its
macromolecular structure.
This study attempted to test the enhancing ability of two absorption enhancers, sodium
glycocholate (Na-GC) and sodium salicylate (Na-Sal), in different parts of rat's gastrointestinal
tract. The amount of insulin in each formulation was 0.6 iu/kg body weight. The
concentration of enhancers (Na-Sal or Na-GC) in each formulation was 10 kg/ml.
Formulations made of insulin and enhancers were prepared and injected directly to stomach,
duodenum, jejunum and ileum of anesthetized rats through an abdominal incision. Blood
samples were taken at 45 and 60 min intervals. The glucose concentration was determined by
the o-toluidine method. Injections (IP) of insulin and normal saline were positive and negative
controls, respectively.
The blood glucose concentrations showed a significant decrease (p<0.05) due to the
injection of insulin into duodenum, while the effect noted in jejunum was insignificant
(p>0.05). Also, there was no anti-hyperglycemic effect accompanied by formulations
administered into the stomach and ileum. It could be concluded that insulin, if formulated in a
protected form to prevent acidic and enzymatic decomposition, in combination with such
enhancers may overcome hyperglycemia due to insulin deficiency.
Keywords :
Absorption enhancer , Salicylate , Glycocholate , Insulin